Integrative Approaches to Cardiometabolic Health: Heart Failure, Diabetes, and Dyslipidemia
Submission Deadline: 31 Dec 2026
Guest Editors

Krishnaswami Vijayaraghavan MD, MSc, FACP, FACC, FHFSA, FNLA
Department of Internal Medicine, Arizona College of Medicine, University of Arizona, Phoenix, AZ, USA
Interests: congenital heart defects; coronary artery disease; heart rhythm disorders and heart failure
Special Issues in IMR Press journals
Special Issue in Heart failure pathogenesis and management: heart failure with preserved ejection fraction
Special Issue in Utilizing Technology in the COVID 19 era

Nishant P. Shah MD, FACC, FAHA, FASPC
Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, NC, USA; Division of Cardiology, Duke Clinical Research Institute, Durham, NC, USA
Interests: cardiometabolic disorders; dyslipidemias; resistant hypertension; obesity; cardiometabolic prevention
Special Issue Information
Dear Colleagues,
Medical specialization has improved our understanding of heart failure (HF), diabetes mellitus (DM), and dyslipidemia, but often leads to fragmented care for patients who must face these conditions together. With nearly half a billion people worldwide living with diabetes which doubles cardiovascular risk, and dyslipidemia which increases disease progression, integrating care is critical. Managing these conditions separately results in excessive use of medication and increases confusion.
This themed issue calls for cohesive, patient-centered cardiometabolic health strategies. We seek submissions exploring cellular connections such as insulin resistance and inflammation, studies on the interplay between DM and HF, lipid roles beyond LDL-C, and integrated clinical approaches involving multidisciplinary teams. Protocols uniting cardiologists, endocrinologists, and primary care are essential to achieve better clinical outcomes in these patients. We therefore welcome insights into team-based models, training, and system-wide collaboration.
Patient engagement remains vital, therefore articles on shared decision-making, outcome tracking, digital tools, advocacy perspectives, and psychological impacts are encouraged. Innovative therapies such as SGLT2 inhibitors and GLP-1 receptor agonists have shown promise in patients with DM and HF. Therefore, it is important to report real-world data, treatment combinations, and strategies to implement these interventions in clinical practice.
Addressing social determinants, disparities, and urban challenges is crucial. We invite research on combined risk factors, food security, community efforts, and policy initiatives. Collaboration among funders, academia, and industry, international partnerships, and advanced methodologies will accelerate progress in this field.
This issue promotes an integrated approach to chronic disease management, aiming to improve outcomes for millions by moving past isolated, piecemeal care.
Prof. Dr. Krishnaswami Vijayaraghavan
Guest Editor
Keywords
- cardiometabolic health
- heart failure
- diabetes
- dyslipidemia
- integrated care
- multidisciplinary
Manuscript Submission Information
Manuscripts should be submitted via our online editorial system at https://imr.propub.com by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted manuscripts should be well formatted in good English.
